Department of Thoracic Malignancy, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, 3-7-1 Habikino Habikino-shi, Osaka, 583-8588, Japan,
Lung. 2014 Feb;192(1):191-5. doi: 10.1007/s00408-013-9516-y. Epub 2013 Oct 20.
Prognostic factors and complicated prognostic models have been proposed for malignant pleural mesothelioma (MPM). This study was designed to stratify MPM prognosis by using a simple model.
Patients diagnosed with MPM in the past 10 years (n = 122) were examined retrospectively. Data on the presence of chest pain, performance status (PS), asbestos exposure, smoking status, white blood cell count (WBC), haemoglobin (Hb) concentration, platelet count (PLT), lactate dehydronate (LD), histology, stage, and date of death or censored status were collected. After the factors were examined in the univariate analysis, recursive partitioning analysis was performed.
Statistically significant factors related to survival were the type of histology, stage, PS, WBC, PLT, Hb concentration, and LD. Histology, stage, PS, and Hb concentration were used in multivariate analysis. Stage and Hb concentration showed good statistical significance, whereas PS was borderline significant. The survival analyses were stratified into five groups by PS, stage, Hb concentration, and chest pain using recursive partitioning analysis. Group A comprised patients showing the most favourable prognoses (PS 0-2 and Hb concentration >12.1 g dL(-1) or PS 0-2 and Hb concentration ≤12.1 g dL(-1) without pain), and group B comprised the remaining patients. The median overall survival in groups A and B was 563 days (95 % confidence interval [CI] 502-779) and 157 days (95 % CI 115-224), respectively (hazard ratio of 5.44 [3.46-8.53, P < 0.0001]).
The MPM patients with PS 0-2 and Hb concentration >12.1 or ≤12.1 g dL(-1) without chest pain had favourable prognoses.
已经提出了用于恶性胸膜间皮瘤(MPM)的预后因素和复杂的预后模型。本研究旨在通过使用简单的模型对 MPM 的预后进行分层。
回顾性检查了过去 10 年中被诊断为 MPM 的患者(n=122)。收集了胸痛、表现状态(PS)、石棉暴露、吸烟状况、白细胞计数(WBC)、血红蛋白(Hb)浓度、血小板计数(PLT)、乳酸脱氢酶(LD)、组织学、分期以及死亡日期或删失状态的数据。在单因素分析中检查了这些因素后,进行了递归分区分析。
与生存相关的统计学显著因素是组织学类型、分期、PS、WBC、PLT、Hb 浓度和 LD。组织学、分期、PS 和 Hb 浓度用于多变量分析。分期和 Hb 浓度显示出良好的统计学显著性,而 PS 则处于边缘显著水平。通过递归分区分析,根据 PS、分期、Hb 浓度和胸痛将生存分析分层为五个组。组 A 包括预后最佳的患者(PS 0-2 和 Hb 浓度>12.1 g/dL(-1)或 PS 0-2 和 Hb 浓度≤12.1 g/dL(-1)且无疼痛),组 B 包括其余患者。组 A 和 B 的中位总生存期分别为 563 天(95%置信区间[CI] 502-779)和 157 天(95%CI 115-224)(风险比为 5.44[3.46-8.53,P<0.0001])。
PS 0-2 且 Hb 浓度>12.1 或≤12.1 g/dL(-1)且无胸痛的 MPM 患者预后良好。